Cosmo Pharmaceuticals NV (OTCPK:CMOPF)
$ 95 0 (0%) Market Cap: 1.19 Bil Enterprise Value: 1.04 Bil PE Ratio: 15.53 PB Ratio: 2.16 GF Score: 84/100

Cosmo Pharmaceuticals NV to Discuss GI Genius™ Call (Q&A Session) Transcript

May 04, 2021 / 02:00PM GMT
Release Date Price: $99
Operator

Ladies and gentlemen, welcome to the GI Genius Q&A session conference call. I am Paul, the Chorus Call operator. (Operator Instructions) The conference is being recorded. (Operator Instructions) The conference must not be recorded for publication or broadcast.

At this time, it's my pleasure to hand over to CEO, Alessandro Della Cha, of Cosmo Pharmaceuticals. Please go ahead, sir.

Alessandro E. Della Cha
Cosmo Pharmaceuticals N.V. - CEO & Executive Director

Good morning, and good afternoon to everyone. Thank you very much for joining our conference call, which, as it has been announced, is particularly crafted in order to allow a Q&A session. We would like to brief you on the potential. We would like to introduce you on the background and future perspective of GI Genius and entertain you on the business potential.

We're going to have 4 speakers today here. There's going to be Mauro Ajani, our Chairman; Andrea Cherubini, who's the Head of our Artificial Intelligence Business; Nhan Ngo Dinh, who is the Head of Research and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot